Results 201 to 210 of about 7,833 (210)

Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors

Biochemical Pharmacology, 2000
Alan J Kraker, H D Hollis Showalter, A J Kraker   +2 more
exaly  

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

EMBO Journal, 1997
Stevan R Hubbard
exaly  

Involvement of Bruton's Tyrosine Kinase in FcεRI-dependent Mast Cell Degranulation and Cytokine Production

Journal of Experimental Medicine, 1998
Chris S Lantz, Mari Maeda-Yamamoto, Anne E Goldfeld   +2 more
exaly  

The Tyrosine Kinase p56lck Mediates Activation of Swelling-induced Chloride Channels in Lymphocytes

Journal of Cell Biology, 1998
A Lepple-Wienhues, Ildikó SZABÓ, Erich Gulbins   +2 more
exaly  

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?

Trends in Endocrinology and Metabolism, 2015
Athanasios Fountas, Agathocles Tsatsoulis   +1 more
exaly  

Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).

Journal of Experimental Medicine, 1994
Mauno Vihinen, Sau-Ping Kwan, Lennart Nilsson   +2 more
exaly  

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway

Cell Metabolism, 2018
Thomas R Larson, Qing Dai, Yuichi J Machida   +2 more
exaly  

Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase.

Journal of Cell Biology, 1995
Christophe Lamaze, Sandra L Schmid
exaly  

A new method for isolating tyrosine kinase substrates used to identify Fish, an SH3 and PX domain-containing protein, and Src substrate

EMBO Journal, 1998
Peter Lock, Toby Gibson, Sara A Courtneidge   +2 more
exaly  

Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

1999
Peter Traxler, Pascal Furet, P Traxler   +2 more
exaly